LT3573631T - Išmatų mikrobiota, skirta gydyti pacientams, kuriems transplantuojamos hemapoetinės kamieninės ląstelės - Google Patents

Išmatų mikrobiota, skirta gydyti pacientams, kuriems transplantuojamos hemapoetinės kamieninės ląstelės

Info

Publication number
LT3573631T
LT3573631T LTEPPCT/EP2018/051941T LT18051941T LT3573631T LT 3573631 T LT3573631 T LT 3573631T LT 18051941 T LT18051941 T LT 18051941T LT 3573631 T LT3573631 T LT 3573631T
Authority
LT
Lithuania
Prior art keywords
stem cell
hematopoietic stem
patients undergoing
treating patients
cell transplant
Prior art date
Application number
LTEPPCT/EP2018/051941T
Other languages
English (en)
Lithuanian (lt)
Inventor
Mohamad Mohty
Harry SOKOL
Original Assignee
Sorbonne Université
Centre National De La Recherche Scientifique
Institut National De La Santé Et De La Recherche Médicale (Inserm)
Assistance Publique - Hôpitaux De Paris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=59325347&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT3573631(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sorbonne Université, Centre National De La Recherche Scientifique, Institut National De La Santé Et De La Recherche Médicale (Inserm), Assistance Publique - Hôpitaux De Paris filed Critical Sorbonne Université
Publication of LT3573631T publication Critical patent/LT3573631T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
LTEPPCT/EP2018/051941T 2017-01-26 2018-01-26 Išmatų mikrobiota, skirta gydyti pacientams, kuriems transplantuojamos hemapoetinės kamieninės ląstelės LT3573631T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1750629A FR3062063B1 (fr) 2017-01-26 2017-01-26 Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques
PCT/EP2018/051941 WO2018138251A1 (fr) 2017-01-26 2018-01-26 Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques

Publications (1)

Publication Number Publication Date
LT3573631T true LT3573631T (lt) 2023-03-10

Family

ID=59325347

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/EP2018/051941T LT3573631T (lt) 2017-01-26 2018-01-26 Išmatų mikrobiota, skirta gydyti pacientams, kuriems transplantuojamos hemapoetinės kamieninės ląstelės

Country Status (20)

Country Link
US (1) US20200188450A1 (https=)
EP (1) EP3573631B1 (https=)
JP (1) JP7527109B2 (https=)
KR (1) KR102517287B1 (https=)
CN (1) CN110520141A (https=)
AU (1) AU2018212530B2 (https=)
CA (1) CA3051807C (https=)
DK (1) DK3573631T3 (https=)
ES (1) ES2937965T3 (https=)
FI (1) FI3573631T3 (https=)
FR (1) FR3062063B1 (https=)
HR (1) HRP20230122T1 (https=)
HU (1) HUE061155T2 (https=)
IL (1) IL268237B (https=)
LT (1) LT3573631T (https=)
PL (1) PL3573631T3 (https=)
PT (1) PT3573631T (https=)
RS (1) RS63978B1 (https=)
SI (1) SI3573631T1 (https=)
WO (1) WO2018138251A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020530494A (ja) * 2017-08-07 2020-10-22 フィンチ セラピューティクス、インコーポレイテッド． 健康な腸バリアを維持及び回復するための組成物及び方法
US20220023419A1 (en) * 2018-11-28 2022-01-27 The Council Of The Queensland Institute Of Medical Research Inhibiting inflammation
CN112375705A (zh) * 2020-11-12 2021-02-19 安徽燕婉健康科技有限公司 一种替代天然菌群的肠壁移植优势菌的制备方法及其应用
EP4386090A1 (en) * 2022-12-12 2024-06-19 Assistance Publique - Hôpitaux De Paris Method for determining and improving the potential efficacy of anticancer treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2649719B1 (fr) * 1989-07-17 1993-08-27 Cerbio Sa Procede de protection et de conservation de micro-organismes notamment de bacteries
US9968638B2 (en) * 2011-03-09 2018-05-15 Regents Of The University Of Minnesota Compositions and methods for transplantation of colon microbiota
EP2922555A4 (en) * 2012-11-26 2016-06-15 Borody Thomas J COMPOSITIONS FOR THE RESTORATION OF A FÄKALBIOZÖNOSE AND METHOD FOR THE PRODUCTION AND USE THEREOF
WO2016057671A1 (en) * 2014-10-07 2016-04-14 University Of Virginia Patent Foundation Compositions and methods for preventing and treating infection
MA41020A (fr) * 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
WO2016086161A1 (en) * 2014-11-25 2016-06-02 Memorial Sloan-Kettering Cancer Center Intestinal microbiota and gvhd
FR3035328B1 (fr) 2015-04-24 2019-08-23 Maat Pharma Procede de preparation d'un echantillon de microbiote fecal
JP6408092B2 (ja) * 2016-08-29 2018-10-17 国立大学法人 東京大学 糞便微生物叢を含む組成物

Also Published As

Publication number Publication date
US20200188450A1 (en) 2020-06-18
IL268237A (en) 2019-09-26
EP3573631B1 (fr) 2022-11-16
IL268237B (en) 2022-07-01
FR3062063B1 (fr) 2019-04-19
PL3573631T3 (pl) 2023-05-02
AU2018212530A1 (en) 2019-09-05
KR102517287B1 (ko) 2023-03-31
CN110520141A (zh) 2019-11-29
CA3051807A1 (fr) 2018-08-02
HUE061155T2 (hu) 2023-05-28
DK3573631T3 (da) 2023-01-30
FI3573631T3 (fi) 2023-03-02
PT3573631T (pt) 2023-01-24
KR20190130563A (ko) 2019-11-22
ES2937965T3 (es) 2023-04-03
RS63978B1 (sr) 2023-03-31
AU2018212530B2 (en) 2022-06-23
WO2018138251A1 (fr) 2018-08-02
FR3062063A1 (fr) 2018-07-27
CA3051807C (fr) 2023-07-11
HRP20230122T1 (hr) 2023-03-31
JP7527109B2 (ja) 2024-08-02
EP3573631A1 (fr) 2019-12-04
JP2020506183A (ja) 2020-02-27
SI3573631T1 (sl) 2023-09-29

Similar Documents

Publication Publication Date Title
SG11202105502RA (en) Methods for treatment using adoptive cell therapy
SG11202104411VA (en) Methods and combinations for treatment and t cell modulation
EP3331582A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF TRANSPLANTATION CELLS
IL250072A0 (en) Transgenic cells for stress cell therapy
EP3229586A4 (en) Genetically modified cells, tissues, and organs for treating disease
IL282447A (en) Methods and preparations for healing eye cell
PT3609550T (pt) Dispositivo de tratamento de células adiposas extraídas de um doente e destinadas a um transplante
EP3138399A4 (en) Composition for organ, tissue, or cell transplantation, kit, and transplantation method
GB201908394D0 (en) Stem cell conditioned media for clinic
IL268237A (en) A tiny fecal creature for the treatment of patients undergoing hematopoietic stem cell transplantation
IL277878A (en) Preparations and methods for stem cell transplantation
IL253389A0 (en) The composition for use in increasing the assembly efficiency of "haematopoietic" stem cells after transplantation
SG10201914102UA (en) Stem cells for wound healing
DK3365432T3 (en) Stem cell therapy based on adipose-derived stem cells
EP3213752A4 (en) Composition for treating cancer stem cells
SG11202105084VA (en) Methods of dosing engineered t cells for the treatment of b cell malignancies
PL3569238T3 (pl) Mezenchymalne komórki macierzyste z trombiną do leczenia noworodkowej hie
IL271022A (en) Compositions and methods for providing cell replacement therapy
SG11201701788YA (en) Pluripotent stem cell for treating diabetic skin ulcer
IL287981A (en) Preparations and methods for the treatment of t-cell exhaustion
PL3132020T3 (pl) Naczynie do hodowli komórek i jego zastosowanie
EP3220996A4 (en) Instruments and methods for loading cells into implantable devices
SG11201605588YA (en) Compositions and methods for treatment of abnormal cell growth
SG11201707857VA (en) Chelated iron-containing culture medium for neural stem cells
IL273934A (en) Methods for treating contractured muscle and related cultured cells